Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
26.61
-0.10 (-0.37%)
At close: Aug 7, 2025, 4:00 PM
26.67
+0.06 (0.21%)
After-hours: Aug 7, 2025, 7:57 PM EDT

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of $10.35 billion. The enterprise value is $3.59 billion.

Market Cap10.35B
Enterprise Value 3.59B

Important Dates

The last earnings date was Friday, August 1, 2025, before market open.

Earnings Date Aug 1, 2025
Ex-Dividend Date n/a

Share Statistics

Moderna has 389.08 million shares outstanding. The number of shares has increased by 1.05% in one year.

Current Share Class 389.08M
Shares Outstanding 389.08M
Shares Change (YoY) +1.05%
Shares Change (QoQ) +0.52%
Owned by Insiders (%) 6.55%
Owned by Institutions (%) 72.55%
Float 363.31M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.34
Forward PS 5.21
PB Ratio 1.10
P/TBV Ratio 1.11
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.17
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.08.

Current Ratio 3.93
Quick Ratio 3.55
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -233.79

Financial Efficiency

Return on equity (ROE) is -27.50% and return on invested capital (ROIC) is -17.69%.

Return on Equity (ROE) -27.50%
Return on Assets (ROA) -14.78%
Return on Invested Capital (ROIC) -17.69%
Return on Capital Employed (ROCE) -31.36%
Revenue Per Employee $530,690
Profits Per Employee -$500,517
Employee Count5,800
Asset Turnover 0.22
Inventory Turnover 16.52

Taxes

Income Tax -42.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -67.67% in the last 52 weeks. The beta is 1.83, so Moderna's price volatility has been higher than the market average.

Beta (5Y) 1.83
52-Week Price Change -67.67%
50-Day Moving Average 29.22
200-Day Moving Average 34.49
Relative Strength Index (RSI) 34.01
Average Volume (20 Days) 8,199,801

Short Selling Information

The latest short interest is 66.24 million, so 17.02% of the outstanding shares have been sold short.

Short Interest 66.24M
Short Previous Month 65.59M
Short % of Shares Out 17.02%
Short % of Float 18.23%
Short Ratio (days to cover) 6.62

Income Statement

In the last 12 months, Moderna had revenue of $3.08 billion and -$2.90 billion in losses. Loss per share was -$7.53.

Revenue3.08B
Gross Profit -2.20B
Operating Income -3.27B
Pretax Income n/a
Net Income -2.90B
EBITDA -3.07B
EBIT -3.27B
Loss Per Share -$7.53
Full Income Statement

Balance Sheet

The company has $5.13 billion in cash and $741.00 million in debt, giving a net cash position of $6.76 billion or $17.38 per share.

Cash & Cash Equivalents 5.13B
Total Debt 741.00M
Net Cash 6.76B
Net Cash Per Share $17.38
Equity (Book Value) 9.40B
Book Value Per Share 24.16
Working Capital 4.60B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.70 billion and capital expenditures -$793.00 million, giving a free cash flow of -$3.49 billion.

Operating Cash Flow -2.70B
Capital Expenditures -793.00M
Free Cash Flow -3.49B
FCF Per Share -$8.97
Full Cash Flow Statement

Margins

Gross margin is -71.44%, with operating and profit margins of -106.34% and -94.31%.

Gross Margin -71.44%
Operating Margin -106.34%
Pretax Margin -95.68%
Profit Margin -94.31%
EBITDA Margin -99.58%
EBIT Margin -106.34%
FCF Margin n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.05%
Shareholder Yield -1.05%
Earnings Yield -28.04%
FCF Yield -33.71%
Dividend Details

Analyst Forecast

The average price target for Moderna is $46.24, which is 73.77% higher than the current price. The consensus rating is "Hold".

Price Target $46.24
Price Target Difference 73.77%
Analyst Consensus Hold
Analyst Count 20
Revenue Growth Forecast (5Y) 17.84%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Moderna has an Altman Z-Score of 5.27 and a Piotroski F-Score of 1.

Altman Z-Score 5.27
Piotroski F-Score 1